Correlation Between Monte Rosa and Protara Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and Protara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and Protara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and Protara Therapeutics, you can compare the effects of market volatilities on Monte Rosa and Protara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of Protara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and Protara Therapeutics.

Diversification Opportunities for Monte Rosa and Protara Therapeutics

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monte and Protara is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and Protara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protara Therapeutics and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with Protara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protara Therapeutics has no effect on the direction of Monte Rosa i.e., Monte Rosa and Protara Therapeutics go up and down completely randomly.

Pair Corralation between Monte Rosa and Protara Therapeutics

Given the investment horizon of 90 days Monte Rosa is expected to generate 1.03 times less return on investment than Protara Therapeutics. In addition to that, Monte Rosa is 1.21 times more volatile than Protara Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. Protara Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest  314.00  in Protara Therapeutics on November 2, 2024 and sell it today you would earn a total of  136.00  from holding Protara Therapeutics or generate 43.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Monte Rosa Therapeutics  vs.  Protara Therapeutics

 Performance 
       Timeline  
Monte Rosa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Monte Rosa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Protara Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Protara Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Protara Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Monte Rosa and Protara Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monte Rosa and Protara Therapeutics

The main advantage of trading using opposite Monte Rosa and Protara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, Protara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protara Therapeutics will offset losses from the drop in Protara Therapeutics' long position.
The idea behind Monte Rosa Therapeutics and Protara Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Directory
Find actively traded commodities issued by global exchanges